Study on abrogation of the capacity of delayed-type hypersensitivity responses to alloantigens and suppression of mixed lymphocyte reaction by portal venous inoculation with allogeneic cells

周海宽,闵志廉,朱有华,于立新
DOI: https://doi.org/10.3760/j.issn:1001-9030.2000.05.023
2000-01-01
Abstract:Objective To study the change of the level of immunoreactions to allogeneic cells after receiving portal venous inoculation with allogeneic cells in mice. Methods Splenocytes from NIH/q or third-party C57/BL spleens were injected into BALB/C hosts via the host portal vein or the systemic vein. Seven days later, BALB/C mice were inoculated on the dorsal flanks with NIH/q mice splenocytes depleted of erythrocytes. Mixed lymphocyte reaction (MLR) of BALB/C to NIH/q mice alloantigens was investigated and anti-NIH/q delayed-type hypersensitivity (DTH) responses assessed by directly challenging NIH/q splenocytes in a volume of 25μl into BALB/C hind footpads 7 days later. Results Portal venous inoculation of NIH/q splenocytes significantly abolished the capability of the animals to develop MLR responses and DTH responses to NIH/q alloantigens as induced by subcutaneous immunization with NIH/q splenocytes ( P 0.05), in which the stimulation index (SI) of MLR was 3.51±0.55, and the footpad increment of DTH was (7.41±0.60)×10 -2 mm. NIH/q mice splenocytes injected via the systemic vein or third-party C57/BL mice splenocytes injected via the portal vein did not abolish the capability of the animals to develop MLR responses and DTH responses to NIH/q alloantigens ( P 0.05), in which the SI of MLR was 34.83± 3.90 and 35.33±2.54, the footpad increment of DTH was (23.51±1.69)×10 -2 mm and (23.87±2.76)×10 -2 mm ( P 0.05). Conclusions Portal venous inoculation of allogeneic cells could induce immunotolerance to alloantigens and this was donor antigen specific.\\;
What problem does this paper attempt to address?